These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia. Layton D; Harris S; Wilton LV; Shakir SA J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184 [TBL] [Abstract][Full Text] [Related]
6. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia]. van Marum RJ; Jansen PA Ned Tijdschr Geneeskd; 2005 Jan; 149(4):165-7. PubMed ID: 15702733 [TBL] [Abstract][Full Text] [Related]
8. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Ballard C; Waite J Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480 [TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics for nursing home patients: a retrospective chart review. Frenchman IB Drugs Aging; 2005; 22(3):257-64. PubMed ID: 15813657 [TBL] [Abstract][Full Text] [Related]
11. Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia. Deberdt WG; Dysken MW; Rappaport SA; Feldman PD; Young CA; Hay DP; Lehman DL; Dossenbach M; Degenhardt EK; Breier A Am J Geriatr Psychiatry; 2005 Aug; 13(8):722-30. PubMed ID: 16085789 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review]. Zuidema SU; van Iersel MB; Koopmans RT; Verhey FR; Olde Rikkert MG Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1565-73. PubMed ID: 16886695 [TBL] [Abstract][Full Text] [Related]
13. Mortality in elderly dementia patients treated with risperidone. Haupt M; Cruz-Jentoft A; Jeste D J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812 [TBL] [Abstract][Full Text] [Related]
14. Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics. Liperoti R; Gambassi G; Lapane KL; Chiang C; Pedone C; Mor V; Bernabei R J Clin Psychiatry; 2005 Sep; 66(9):1090-6. PubMed ID: 16187764 [TBL] [Abstract][Full Text] [Related]
15. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
16. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia. Martin H; Slyk MP; Deymann S; Cornacchione MJ J Am Med Dir Assoc; 2003; 4(4):183-8. PubMed ID: 12837138 [TBL] [Abstract][Full Text] [Related]
17. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. Gareri P; De Fazio P; Manfredi VG; De Sarro G J Clin Psychopharmacol; 2014 Feb; 34(1):109-23. PubMed ID: 24158020 [TBL] [Abstract][Full Text] [Related]
18. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. Maust DT; Kim HM; Seyfried LS; Chiang C; Kavanagh J; Schneider LS; Kales HC JAMA Psychiatry; 2015 May; 72(5):438-45. PubMed ID: 25786075 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of atypical antipsychotics in elderly patients with dementia. Tariot PN; Profenno LA; Ismail MS J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966 [TBL] [Abstract][Full Text] [Related]